Life Science

Rgenta Therapeutics Moves to Woburn

Rgenta’s lab at 300 TradeCenter 128

Woburn, MA – Rgenta Therapeutics, a biotechnology company developing oral treatments for historically incurable diseases, has leased 5,400sf at TradeCenter 128 in Woburn, a business and technology campus managed by Cummings Properties.

“Having outgrown our shared space in Cambridge, we were determined to find a convenient, high-value location that would support our continued evolution,” said Rgenta CEO and co-founder, Simon Xi, Ph.D.

TradeCenter 128

Rgenta’s team of small-molecule drug developers is currently focused on pioneering new medicines for cancers and neurological disorders. The new space is a Biosafety Level 2 facility and features a newly constructed cell-culture room, specialty gas distribution, and an expansive window line as well as new benchwork, fume hoods, and HVAC.

Cummings Properties account manager, Eric Lawless, worked with Newmark director, Catie Tilton, on the lease which included a custom lab and office buildout. Floor-to-ceiling glass partitions separate Rgenta’s offices from its laboratory, providing a view that includes the Boston skyline from virtually any vantage point in the suite.

Cummings’ architecture and construction teams designed and built the facility in four months.